BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7926008)

  • 1. The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.
    Choi DS; Birraux G; Launay JM; Maroteaux L
    FEBS Lett; 1994 Oct; 352(3):393-9. PubMed ID: 7926008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse 5-HT2B receptor: possible involvement in trophic functions of serotonin.
    Choi DS; Colas JF; Kellermann O; Loric S; Launay JM; Rosay P; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):403-11. PubMed ID: 7920184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras involvement in signal transduction by the serotonin 5-HT2B receptor.
    Launay JM; Birraux G; Bondoux D; Callebert J; Choi DS; Loric S; Maroteaux L
    J Biol Chem; 1996 Feb; 271(6):3141-7. PubMed ID: 8621713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and functional characterization of the human 5-HT2B serotonin receptor.
    Schmuck K; Ullmer C; Engels P; Lübbert H
    FEBS Lett; 1994 Mar; 342(1):85-90. PubMed ID: 8143856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
    Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
    Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
    Parker EM; Izzarelli DG; Lewis-Higgins L; Palmer D; Shapiro RA
    J Neurochem; 1996 Nov; 67(5):2096-103. PubMed ID: 8863519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential expression of 5-HT1D over 5-HT1B receptors during early embryogenesis.
    Bolaños-Jiménez F; Choi DS; Maroteaux L
    Neuroreport; 1997 Dec; 8(17):3655-60. PubMed ID: 9427346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells.
    Choi DS; Ward SJ; Messaddeq N; Launay JM; Maroteaux L
    Development; 1997 May; 124(9):1745-55. PubMed ID: 9165122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of a human serotonin 5-HT4 receptor cDNA.
    Van den Wyngaert I; Gommeren W; Verhasselt P; Jurzak M; Leysen J; Luyten W; Bender E
    J Neurochem; 1997 Nov; 69(5):1810-9. PubMed ID: 9349523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    Porter RH; Benwell KR; Lamb H; Malcolm CS; Allen NH; Revell DF; Adams DR; Sheardown MJ
    Br J Pharmacol; 1999 Sep; 128(1):13-20. PubMed ID: 10498829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
    Shen Y; Monsma FJ; Metcalf MA; Jose PA; Hamblin MW; Sibley DR
    J Biol Chem; 1993 Aug; 268(24):18200-4. PubMed ID: 8394362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2 receptor subtypes: a family re-united?
    Baxter G; Kennett G; Blaney F; Blackburn T
    Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
    Bonaventure P; Nepomuceno D; Miller K; Chen J; Kuei C; Kamme F; Tran DT; Lovenberg TW; Liu C
    Eur J Pharmacol; 2005 Apr; 513(3):181-92. PubMed ID: 15862800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of human 5-HT2 receptor subtypes.
    Jerman JC; Brough SJ; Gager T; Wood M; Coldwell MC; Smart D; Middlemiss DN
    Eur J Pharmacol; 2001 Feb; 414(1):23-30. PubMed ID: 11230991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel serotonin receptor from Caenorhabditis elegans: cloning and expression of two splice variants.
    Hamdan FF; Ungrin MD; Abramovitz M; Ribeiro P
    J Neurochem; 1999 Apr; 72(4):1372-83. PubMed ID: 10098838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel discriminatory ligands for 5-HT2B receptors.
    Baxter GS
    Behav Brain Res; 1996; 73(1-2):149-52. PubMed ID: 8788493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
    Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
    J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
    Schaerlinger B; Hickel P; Etienne N; Guesnier L; Maroteaux L
    Br J Pharmacol; 2003 Sep; 140(2):277-84. PubMed ID: 12970106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.